According to Hims & Hers Health's latest financial reports the company's current EPS (TTM) is -$0.22. In 2022 the company made an earnings per share (EPS) of -$0.32 an increase over its 2021 EPS that were of -$0.62.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.22 | -31.25% |
2022 | -$0.32 | -48.39% |
2021 | -$0.62 | 44.19% |
2020 | -$0.43 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$2.06 | 836.36% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$6.20 | 2,718.18% | ๐ฌ๐ง UK |
Novavax NVAX | -$7.19 | 3,168.18% | ๐บ๐ธ USA |
Novocure
NVCR | -$1.86 | 745.45% | Jersey |